首页> 美国卫生研究院文献>Clinical and Experimental Gastroenterology >Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease
【2h】

Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease

机译:小儿克罗恩病肿瘤坏死因子α诱导蛋白3(A20)失调

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeA significant feature of pediatric inflammatory bowel diseases (IBD), which include Crohn disease (CD), and ulcerative colitis (UC), is failure to suppress inflammation. The inability to regulate inflammation renders a major challenge toward establishing effective treatments in IBD. Nuclear factor kappa-light-chain-enhancer of activated B-cells-induced inflammation is inhibited by A20 through interactions with TAX1BP1 (Tax1-binding protein 1) and A20-binding inhibitor of NF-κβ activation (ABIN)-1 (A20 binding and inhibitor of NF-κβ) and upon phosphorylation by inhibitor of nuclear factor kappa-β kinase subunit beta (IKKβ), which stabilizes it. We hypothesized that dysregulation of A20 is an important factor in uncontrolled inflammation in pediatric IBD.
机译:目的包括克罗恩病(CD)和溃疡性结肠炎(UC)在内的小儿炎症性肠病(IBD)的重要特征是无法抑制炎症。无法调节炎症提出了在IBD中建立有效治疗的主要挑战。 A20通过与TAX1BP1(Tax1结合蛋白1)和A20结合的NF-κβ激活抑制剂(ABIN)-1(A20结合)相互作用来抑制活化的B细胞诱导的炎症的核因子κ轻链增强剂NF-κβ抑制剂)和被核因子kappa-β激酶亚基β(IKKβ)抑制剂磷酸化后使其稳定。我们假设A20失调是小儿IBD炎症失控的重要因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号